The Ultimate Guide to Body Jewelry Materials: Safety, Allergies, and Compliance

ASTM F136 is the standard specification for wrought titanium-6 aluminium-4 vanadium ELI (extra low interstitial) alloy for surgical implant applications. It mandates a specific composition: titanium balance, 5.50–6.50% aluminium, 3.50–4.50% vanadium, with strict limits on iron (0.25% max), oxygen (0.13% max), carbon (0.08% max), nitrogen (0.05% max), and hydrogen (0.012% max). It also specifies minimum mechanical properties: tensile strength of 860 MPa minimum and yield strength of 795 MPa minimum in the annealed condition.

What ASTM F136 certifies, in practical terms: the metal is free of nickel as an intentional alloying element, the interstitial elements (oxygen, nitrogen, carbon) that make titanium brittle are tightly controlled, and the material has been produced under a quality system that a mill test report (MTR) can document. That last part matters. The MTR is the paper trail that proves the bar in your hand came from a certified heat of metal.

"Surgical steel" certifies none of this. It is a commercial label, not a standard. The term most often refers to 316L stainless steel, which contains 10–14% nickel by weight. But it can also refer to 304 stainless steel (8–10.5% nickel), 316LVM (vacuum-melted 316L), or even unspecified grades. There is no regulatory body that verifies the term, and no test report that accompanies it by default. A supplier who calls their jewellery "surgical steel" is making a marketing claim. A supplier who provides an ASTM F136 MTR with a traceable heat number is providing a material fact. The Biocompatibility Material Checker walks through the documents that distinguish one from the other.

ISO 10993 is the international standard series for biological evaluation of medical devices. For body jewellery that is in prolonged contact with breached or intact skin, the relevant parts are:

• ISO 10993-1: Evaluation and testing within a risk management process. This is the framework that determines which tests apply based on contact duration and tissue type.
• ISO 10993-5: Tests for in vitro cytotoxicity. Measures whether the material kills cells in culture. A pass here is the minimum baseline for any material claiming biocompatibility.
• ISO 10993-10: Tests for skin sensitisation. Determines whether repeated exposure to the material triggers an allergic response. This is the test most relevant to the nickel-sensitisation question.
• ISO 10993-6: Tests for local effects after implantation. Evaluates tissue response to a material placed inside living tissue. For polymeric jewellery, this is the test that matters most.

A supplier who says their material "meets ISO 10993" should be able to tell you which parts and what the test results were. A blanket claim with no part numbers and no test house name is the materials equivalent of a blank consent form.

A legitimate mill test report contains three things a marketing document does not: a heat number that traces to a specific pour of metal, the chemical analysis of that heat (all elements, not just the ones the supplier wants to highlight), and the mechanical test results (tensile, yield, elongation, reduction of area). The heat number is the linchpin. Without it, the chemical analysis is unverifiable. A certificate that lists composition but no heat number is a typed list, not a mill test report.

The three documents that together form a complete certification trail: the mill test report (from the mill that poured the metal), the certificate of analysis (from the manufacturer who worked the metal into jewellery), and the Declaration of Conformity (the manufacturer's statement that the finished product meets the claimed standards). Red flags: a CoA that restates the MTR chemistry without adding any processing data, an MTR with no testing laboratory accreditation mark (ISO 17025), and a heat number that cannot be traced because the mill that supposedly poured it no longer exists. The Biocompatibility Material Checker provides a structured checklist for evaluating these documents.

This is the distinction that separates material science from internet forum wisdom. 316LVM stainless steel is 10–14% nickel by composition. That is a lot of nickel to have inside a piece of jewellery sitting in a healing piercing. And yet, properly passivated 316LVM releases nickel at rates below the clinical sensitisation threshold. The reason is the chromium oxide passivation layer.

Stainless steel forms a self-healing chromium oxide film on its surface when exposed to oxygen. This film is approximately 2–5 nanometres thick, chemically stable, and electrically insulating. It acts as a physical barrier that prevents nickel ions in the alloy matrix from migrating to the surface and dissolving into surrounding tissue fluid. The film is what makes the steel "stainless": the chromium oxidises preferentially and seals the surface.

What destroys the passivation layer: mechanical scratching (even micro-abrasion from cleaning cloths), chloride exposure (saline solution, sweat, swimming pools), and low pH environments (infected tissue, certain aftercare products). Once the film is breached, the nickel underneath becomes available for release. This is why a 316L bar that performed fine for months can suddenly trigger a reaction: the passivation layer was gradually worn thin by daily friction until it failed at a localised point. The Nickel Release Calculator (EN 1811) models the variables that affect release rate.

EN 1811 is the European reference test method for nickel release from post-assembly piercing jewellery. The test simulates one week of skin contact: the jewellery is immersed in an artificial sweat solution at 30°C for 168 hours, and the nickel concentration in the solution is then measured by ICP-MS (inductively coupled plasma mass spectrometry).

The legal limits under REACH Annex XVII, entry 27:

• 0.2 µg/cm²/week for post-assembly piercing jewellery (the stricter limit, because the jewellery sits inside healing or healed tissue with a direct fluid interface).
• 0.5 µg/cm²/week for other articles intended to come into direct and prolonged contact with the skin (necklaces, bracelets, watch cases).

A piece that passes EN 1811 at 0.2 µg/cm²/week has demonstrated that its passivation layer is intact and doing its job under simulated physiological conditions. A piece that has never been tested to EN 1811 may passivate perfectly or may release far more nickel than the label suggests. There is no visible way to know. The Nickel Release Calculator applies the EN 1811 framework to jewellery specifications so you can estimate release risk from measurable parameters.

Nickel allergy is a Type IV delayed hypersensitivity reaction, mediated by T-cells rather than antibodies. Sensitisation occurs through repeated low-level skin exposure to nickel ions. The ions penetrate the epidermis, bind to skin proteins, and form hapten-protein complexes that the immune system learns to recognise as foreign. Once sensitised, the threshold for a reaction drops significantly: a person who initially tolerated daily exposure to a 316L necklace may develop a reaction to the same necklace months later because cumulative sensitisation has lowered their tolerance.

Clinical presentation: localised eczema, erythema, papules, and pruritus appearing 12–48 hours after exposure. The reaction is confined to the contact site but can spread in severe cases. The critical clinical distinction: a nickel reaction at a piercing site looks similar to an infection in its early stages (redness, swelling, discharge), but it will not respond to antibiotics and will persist as long as the nickel source remains in contact with tissue. The Nickel Allergy & Sensitisation wiki covers the immunology in detail.

Commission Regulation (EU) 2020/2081, enacted under REACH Annex XVII, entry 75, restricts substances in tattoo inks and permanent make-up. The regulation targets specific pigments and chemicals known or suspected to be carcinogenic, mutagenic, or reprotoxic (CMR), or to be skin sensitisers or irritants.

The most consequential bans:

• Pigment Blue 15:3 (CAS 147-14-8) and Pigment Green 7 (CAS 1328-53-6): copper phthalocyanine pigments, the most widely used blue and green colorants in tattoo ink globally. Banned at any concentration as of 4 January 2022 for Pigment Blue 15 and 4 January 2023 for Pigment Green 7, with no safe minimum.
• Pigment Violet 23 (CAS 6358-30-1): a dioxazine pigment used for purple ink. Restricted under the same timeline as Pigment Green 7.
• PAHs (polycyclic aromatic hydrocarbons): restricted as impurities, not as intentional ingredients. Carbon black pigments commonly contain PAHs as byproducts of incomplete combustion during manufacture. The regulation sets maximum PAH concentration limits per individual compound.

The practical impact: a tattoo ink that was legal in the EU before January 2022 may be illegal today, even if the bottle on the shelf looks identical. The regulation applies to the substance, not the packaging. Studios that bought ink before the restriction dates and still have it in inventory are holding non-compliant product. The Tattoo Ink Ingredient Decoder cross-references ink SDS data against the REACH restriction list.

The Substances of Very High Concern (SVHC) Candidate List is maintained by ECHA under REACH Article 59. Substances are added when they meet one or more of the criteria: CMR category 1A or 1B, persistent, bioaccumulative and toxic (PBT), very persistent and very bioaccumulative (vPvB), or of equivalent concern (such as endocrine disruptors).

Once a substance is on the Candidate List, suppliers of articles containing that substance above 0.1% weight-by-weight must provide the recipient with sufficient information to allow safe use, including as a minimum the name of the substance (Article 33 duty to communicate). For a tattoo studio, this means: if an ink contains an SVHC above 0.1% w/w, the ink manufacturer must tell you. If they do not, they are in breach of REACH. The reverse is not automatically safe: the absence of an Article 33 communication does not guarantee the absence of SVHCs. The onus is on the supplier, but verification is on the user.

The list grows regularly. ECHA adds substances in batches (roughly twice per year), and each addition carries a deadline after which the Article 33 duty applies. The REACH SVHC Pigment Checker monitors the Candidate List and cross-references it against known tattoo ink and jewellery material components.

An SDS is a 16-section document standardised under REACH Annex II. For tattoo ink and jewellery material evaluation, three sections carry the weight:

• Section 2: Hazards identification. Look for hazard statements (H-phrases) and precautionary statements (P-phrases). H317 ("may cause an allergic skin reaction") is a common finding in inks containing nickel or cobalt compounds. H340/H350/H360 indicate mutagenicity, carcinogenicity, or reproductive toxicity, respectively.
• Section 3: Composition/information on ingredients. This is the centre of the document. It lists the chemical identity (CAS number, EC number), concentration or concentration range, and classification of each hazardous ingredient. A substance listed here with a CAS number and a hazard classification is the one to cross-reference against the SVHC Candidate List and the REACH Annex XVII restrictions.
• Section 15: Regulatory information. This section cites the specific regulations that apply to the substance or mixture. For an EU-compliant ink, look for references to Regulation (EC) No 1272/2008 (CLP), Regulation (EU) 2020/2081 (tattoo ink restriction), and any national-level additional restrictions.

An SDS that lists no hazardous ingredients in Section 3 is either a simple product or an incomplete document. An SDS that lists ingredients by generic trade name rather than CAS number is not compliant with REACH Annex II and should be treated as insufficient. The Tattoo Ink Ingredient Decoder and REACH SVHC Pigment Checker together handle the cross-referencing workflow.

ASTM F2503 is the standard practice for marking medical devices and other items for safety in the magnetic resonance environment. It defines three categories:

• MR Safe: An item that poses no known hazards in all MR environments. Materials: non-conducting, non-metallic, non-magnetic (e.g., glass, certain polymers). In body jewellery, BioFlex polymer and PTFE fall into this category.
• MR Conditional: An item that has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Most implant-grade metals fall here: ASTM F136 titanium (non-ferromagnetic, but conductive and can cause RF-induced heating under certain scan parameters), certain grades of austenitic stainless steel, and niobium. The conditions specify maximum static magnetic field strength (typically 1.5T or 3T), maximum spatial gradient field, and maximum specific absorption rate (SAR).
• MR Unsafe: An item that is known to pose hazards in all MR environments. Ferromagnetic steels (martensitic stainless, most carbon steels), magnetic implant materials, and anything containing iron above the ferromagnetic threshold. In body jewellery, low-grade "surgical steel" that is actually a ferromagnetic grade falls here.

The clinical reality is that most implant-grade titanium body jewellery is MR Conditional at 1.5T and 3T, but radiographers need the documentation to confirm. The MRI Safety Checker provides a material-based assessment framework for common jewellery alloys.

Three distinct hazards, all governed by the physics of the static magnetic field (B0) and the radiofrequency (RF) field:

Projectile risk (the missile effect). A ferromagnetic object in the fringe field of an active MRI magnet experiences a translational force proportional to the product of the object's magnetic susceptibility, the magnetic field strength, and the spatial gradient of the field. At 3T, the force on a small ferromagnetic earring can exceed several kilograms. The object accelerates into the bore, passing through anything in its path.

RF-induced heating. The RF pulses used to excite proton spins induce currents in conductive materials. A closed conducting loop (a continuous ring, a circular barbell through two piercings connected by tissue) acts as an inductive coil. The induced current generates resistive heating at the points of highest resistance, typically the tissue-jewellery interface. Burns at piercing sites during MRI are documented in the clinical literature, including cases where the jewellery was not ferromagnetic but formed a conductive loop.

Image artefact. Even non-ferromagnetic metal distorts the local magnetic field homogeneity, creating signal voids (black holes) and geometric distortion in the image. The artefact size depends on the magnetic susceptibility difference between the metal and tissue. Titanium produces smaller artefacts than stainless steel, but both produce artefacts large enough to obscure anatomy within several centimetres of the jewellery.

The practical rule: remove metal jewellery when the scan region includes the jewellery site. For jewellery that cannot be removed (healed piercings with fixed jewellery), provide the radiographer with the material specification and certification so they can make an informed call. The MRI Safety Checker covers the decision framework.

A controlled material exposure test before committing to permanent jewellery is the most reliable way to identify a material sensitivity in a specific client. The protocol:

1. Select test samples: small discs or short bars of each candidate material (ASTM F136 titanium, niobium, BioFlex polymer, PTFE), cleaned and sterilised to the same standard as wearable jewellery.
2. Apply to skin: tape each sample to the inner forearm or behind the ear, areas with thin skin and good vascularity that mirror healing piercing conditions. Use hypoallergenic medical tape.
3. Wait 96 hours: keep the test patches dry and in place for four full days. This duration is sufficient for a Type IV hypersensitivity reaction to develop if the client is sensitised.
4. Read the result: remove the patches and inspect each site. A positive reaction presents as localised erythema, papules, or vesicles at the contact site. A negative test shows no change from surrounding skin.
5. Document: photograph each test site, record the material and lot number, and add the result to the client's file.

A negative 96-hour patch test for a specific material does not guarantee the client will never react. Sensitisation can develop over time with repeated exposure. But it is the strongest pre-procedure evidence available that the material is compatible at the time of testing. The Allergy Patch Test Protocol Generator produces a customised protocol for each client.

When a client reports metal sensitivity, the material selection follows a tiered approach from highest to lowest reaction risk:

• Titanium, ASTM F136 (Ti-6Al-4V ELI): the first-line material. Nickel-free as an intentional alloying element. Vanadium and aluminium are present but are tightly bound in the alloy matrix and do not release at biologically significant levels from a properly passivated surface. Suitable for the vast majority of metal-sensitive clients.
• Niobium: pure elemental metal (not an alloy). Completely nickel-free, vanadium-free, and aluminium-free. Biocompatibility is excellent, and the metal anodises to a wide colour range without dyes or coatings. The trade-off: niobium is softer than titanium and can bend under mechanical load at thin gauges. It is the fallback when a client reacts to titanium (a rare but documented occurrence).
• BioFlex polymer (PP-R): a polypropylene random copolymer, metal-free and radiolucent. No nickel, no vanadium, no aluminium, no metal ions of any kind. MR Safe per ASTM F2503. Flexible enough to absorb mechanical shock without transferring force to the fistula. The material of choice for clients with confirmed multiple-metal sensitivity, for initial piercings where metal reactivity is unknown, and for MRI and surgical retention.
• PTFE (polytetrafluoroethylene): a fully fluorinated polymer, also metal-free. More rigid than BioFlex, with a lower coefficient of friction. Used primarily for retainers and for clients who need a completely inert surface. Less comfortable for long-term wear in curved placements because it does not flex to match tissue movement.

The ladder is not a ranking of quality. It is a ranking of reaction risk, descending. The correct material is the one the client's immune system tolerates, not the one highest on the list. The Biocompatibility Material Checker evaluates each material against the standards that apply to it.

The piercer's scope ends where systemic allergy begins. Refer when: the reaction extends beyond the piercing site (satellite lesions, generalised eczema), the client reports reactions to multiple unrelated materials (jewellery, watch cases, jean buttons, coins), the reaction does not resolve within 48 hours of removing the suspected material, or the client presents with a known diagnosis of systemic nickel allergy syndrome (SNAS). A dermatologist can perform patch testing with a standardised allergen panel that identifies the specific metal salts the client reacts to. The piercer's material knowledge informs the referral; the dermatologist's test results inform the material selection.